Trixim

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trixim

Property Description
Active ingredient Cefixime (as Trihydrate)
Form Tablet, Capsule, Oral Suspension
Pharmacological class Third-generation Cephalosporin, beta-lactam Antibiotic
Common use Clearing Bacterial Infections
Origin Synthetic

Trixim is a synthetic prescription-only medicine (POM) defined fundamentally as an antibiotic used to manage infections caused by pathogenic bacteria. Its core function is to act as a bactericidal agent, meaning it actively kills the target organisms rather than merely slowing their growth. The medication is categorized as a Third-generation Cephalosporin, representing an advanced member of the broader beta-lactam family of antimicrobial agents. This means the medicine is clinically recognized for its critical role in fighting bacterial illness.


What Type of Medicine is Trixim (Cefixime)?

Trixim is a Third-generation Cephalosporin, a specific class of broad-spectrum antibiotics utilized for clearing established bacterial infections. Its profile is often highlighted for its high oral bioavailability, a quality supported by extensive pharmacological studies, which makes it a preferred option for systemic oral administration.

The medicine's effectiveness stems from its active ingredient, Cefixime, which is produced entirely through chemical synthesis, classifying it as a synthetic compound. As a beta-lactam antibiotic, Cefixime works by interfering with the vital process of bacterial cell wall synthesis. This targeted action ensures a direct and definitive elimination of susceptible bacteria through cellular breakdown, which is critical for infection resolution, such as in cases of community-acquired respiratory illness.


Composition and General Purpose

The composition of Trixim is centered on a single product approach, containing Cefixime as the sole active compound. This active ingredient is formulated into several standard pharmaceutical preparations suitable for systemic oral administration. These forms include the classic tablet and capsule, alongside a highly important oral suspension (prepared from a dry powder). The general purpose of Trixim is the swift and effective clearance of bacterial infections by eliminating the responsible disease-causing organisms.

Regulatory References

  1. Cephalosporin Antibiotics
  2. β-Lactam Antibiotics

What side effects are possible with Trixim?

Possible Side Effects and Safety Information

The safety profile of Trixim is based on data derived from authoritative governmental health agencies. Side effects are classified by their frequency, which helps patients understand the likelihood of experiencing them.


Frequency-Classified Adverse Reactions

The most frequently documented side effects involve the Gastrointestinal System. Events are categorized as follows:

Classification Examples of Documented Reactions
Very Common Diarrhea, Nausea, Loose Stools
Common Headache, Dizziness, Rash, Transient liver enzyme elevation
Rare / Very Rare Anaphylactic Shock, Toxic Epidermal Necrolysis (TEN)

Clinically Significant Adverse Reactions

Serious Adverse Reactions officially listed in regulatory documents include Anaphylactic Shock and severe skin reactions such as Stevens-Johnson syndrome and TEN, which require immediate discontinuation and medical attention. Risk of severe diarrhea, or Pseudomembranous Colitis, is also documented as a possible serious adverse reaction that may occur during or after treatment.

Specific Safety Considerations

The use of Trixim requires Safety Restrictions and Monitoring under certain conditions:

  • Contraindications: Trixim is contraindicated in patients with a known history of severe hypersensitivity reactions to the drug or to other cephalosporin-class medicines.
  • Renal Impairment: Dose adjustments are officially required for individuals with moderate to severe renal impairment (creatinine clearance less than 60 mL/min) to mitigate the risk of accumulation and potential toxicity.
  • Monitoring: The label specifies that patients should be evaluated for Clostridium difficile-associated diarrhea (CDAD) if persistent diarrhea develops, and liver function should be monitored in certain clinical contexts.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below describes the official, regulator-documented profile of Trixim overdose and the mandated actions required.

Overdose Scope

Property Description (Strictly Regulatory-Derived)
Documented overdose presentations The primary documented risk is encephalopathy, a severe neurological condition. Manifestations may include convulsions (seizures), confusion, impaired consciousness, and movement disorders.
Physiological systems affected (as stated in label) The primary system affected is the Central Nervous System (CNS).
Dose-related or exposure-related factors Adverse reactions observed at single doses up to 2 g in healthy volunteers did not differ substantially from the profile seen at recommended therapeutic doses.
Population-specific overdose notes The risk of encephalopathy is noted to be heightened particularly in cases of overdose occurring concurrently with renal impairment.
Emergency-response statements Contact the Poison Help line for advice. Treatment is recommended as general supportive measures.
When immediate medical help is required (label-derived phrasing only) Immediately call emergency services if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Overdose Classifications (High-Level)

Property Description (Strictly Regulatory-Derived)
Severity classification Defined by the potential for severe neurological outcomes such as encephalopathy and convulsions, which necessitate immediate emergency action.
Regulatory basis Based on official Prescribing Information and governmental regulatory documents.
Overdose-context constraints No specific antidote exists for the overdose. The drug is not removed in significant quantities by hemodialysis or peritoneal dialysis. Gastric lavage may be indicated.

Resulting Overdose Structure

Official overdose statements:

  • The most significant documented severe risk is encephalopathy, with manifestations including convulsions and impaired consciousness.
  • Immediate contact with emergency services is mandated for severe signs such as seizure, collapse, or being unable to be awakened.
  • No specific antidote is available, and procedures such as dialysis are stated as being ineffective for drug removal in overdose.

Connection to the overall overdose profile (193 words total): Regulatory documents define the overdose profile by prioritizing the central nervous system toxicity as the most significant severe outcome. This risk, combined with the explicit statement that no specific antidote exists and that dialysis is not effective, mandates that management focuses on symptomatic and general supportive care. Urgent medical help is required when specific, life-threatening symptoms (e.g., seizure or collapse) are observed, exactly as described by regulatory authorities.

Therapeutic Uses of Trixim

Trixim is applied across domains where additional symptomatic support is needed, addressing symptoms related to physical discomfort associated with bacterial infections across several key body systems. It is relevant in clinical settings marked by heightened patient distress. The medication is commonly used to help with a wide range of bacterial infections.

Understanding Therapeutic Focus

The medication is commonly used across conditions presenting with acute episodes, including uncomplicated urinary tract infections (UTIs), acute otitis media (ear infection), tonsillitis, pharyngitis, and acute exacerbations of chronic bronchitis. This medication helps address symptom clusters that may appear suddenly and create noticeable physiological strain. It is relevant when supportive symptom management is appropriate, applied during phases when symptoms become more noticeable associated with these acute infections.

“The action against the infectious source supports symptomatic relief which helps improve day-to-day comfort during difficult episodes.”

This oral therapy may assist with easing challenging symptoms like high fever, painful swallowing, and dysuria (painful urination), supporting the patient during difficult episodes by easing distress.

Quick Fact: Support for Infection-Related Discomfort Trixim is applied across domains where additional symptomatic support is needed, assisting with the process of easing symptoms related to inflammatory or irritative states.

Regulatory References

  1. NIH MedlinePlus overview on Cefixime

Eligibility and Restrictions for Use

Trixim (cefixime) is an antibiotic prescribed to treat a variety of bacterial infections, including those of the ear, throat, urinary tract, and lungs. However, its use is contraindicated and requires caution in certain patient groups.

Who Should NOT Use Trixim?

Trixim should not be used by individuals with a known allergy or hypersensitivity to cefixime or any other cephalosporin-class antibiotics. Given the possibility of cross-sensitivity, patients with a history of severe allergic reactions (such as anaphylaxis) to penicillin-class antibiotics should use Trixim with extreme caution.


Use in Specific Populations

Population General Recommendation
Children under 6 months Safety and efficacy have not been established in this age group.
Pregnant women Should only be used if clearly necessary, as adequate and well-controlled studies in pregnant women are lacking. The potential benefits must outweigh the potential risks to the fetus.
Breastfeeding women Use should be avoided or conducted with caution; a decision to discontinue nursing temporarily should be made by a healthcare provider, considering that it is not known whether the drug is excreted in human milk.
Patients with Severe Kidney Impairment Dosage adjustment is necessary to prevent accumulation of the drug, as Trixim is primarily eliminated by the kidneys.
Patients with Colitis Should be administered with caution due to the risk of Clostridium difficile-associated diarrhea, which can be severe.

What should I know about interactions with other medicines?

Trixim Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Trixim (Cefixime) as published in government regulatory sources, strictly detailing interactions with other substances and products.


Documented Exposure-Modifying and Pharmacodynamic Interactions

Interacting Substance Official Regulatory Effect
Anticoagulants (e.g., Warfarin) Associated with prolonged prothrombin time; co-administration increases the risk of bleeding effects.
Probenecid Increases Trixim plasma levels (Cmax and AUC) due to decreased renal clearance.
Salicylates (e.g., 650 mg dose) Decreases Trixim plasma levels (Cmax and AUC) by up to 25%.
Carbamazepine Reports of elevated plasma levels of Carbamazepine when co-administered with Trixim.

No medicinal products are formally classified as contraindicated combinations, and no mandatory timing separation rules are specified in the official labels. Trixim tablets and capsules may be taken without regard to food, as absorption is not significantly affected.


Official Laboratory Test Interference

Trixim may cause false-positive results for several laboratory tests. These include the direct Coombs test, tests for glucose in the urine using Clinitest or Benedict's solution, and tests for ketones in the urine using nitroprusside.


Population-Specific Cautions

Patients with impaired renal function require dose adjustment due to decreased clearance of Cefixime, as they face an increased risk of potential neurological symptoms. Patients with hepatic impairment are identified as having a heightened risk of coagulation effects if they are also receiving anticoagulant therapy.

Mechanism of Action

How Trixim Works

Trixim, containing Cefixime, is a bactericidal medicine whose function relies on the inhibition of a structure unique to bacteria: the cell wall. The mechanism results in the death of the susceptible organism.


Inhibition of Bacterial Cell Wall Assembly

Cefixime works by acting as an irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), which are enzymes crucial for building the cell wall. By covalently binding to these enzymes, the drug halts the essential cross-linking of peptidoglycan strands, preventing the formation of a rigid, cross-linked bacterial wall structure.

The drug exhibits inherent stability against many common beta-lactamase enzymes, which are bacterial defense mechanisms.


The Bactericidal Cascade and Pathogen Clearance

The inhibition of PBP activity leads immediately to a critically defective cell wall that cannot withstand the high internal osmotic pressure of the bacterium. This cellular structural failure causes the bacterial cell to swell and rupture (lysis), initiating the bactericidal cascade. This process results in the destruction and clearance of susceptible bacterial populations within the physiological system.

Dosage and Administration Information

How Trixim is Used: Official Administration Guidelines

Trixim (Cefixime) is a prescription-only medicine administered for systemic use strictly via the oral route. It is available in several forms designed for ingestion, including tablets (100 mg, 200 mg, 400 mg), capsules (400 mg), and an oral suspension.


Standard Dosing and Frequency

The standard recommended regimen for adults (and children over 45 kg or 12 years of age) is a total daily dose of 400 mg. This dose may be taken in two ways:

  • Once daily: A single dose of 400 mg per day.
  • Divided dose: 200 mg taken every 12 hours.

For certain uncomplicated infections, guidelines specify a single 400 mg oral dose. The tablets and capsules may be taken without regard to food.


Use Duration and Preparation

The typical duration of treatment is 7 to 14 days. However, for infections known or suspected to be caused by Streptococcus pyogenes, treatment must be continued for a minimum of 10 days.

If using the oral suspension, it must be shaken well before each dose, and the reconstituted mixture must be discarded after 14 days.


Population-Specific Adjustments

Dose modification is required for patients with reduced kidney function. For adults with a creatinine clearance (CrCl) of 60 mL/min or less, the daily dosage must be reduced. For example, a dose of 200 mg once daily is typically recommended for patients with severe impairment (CrCl le 20 mL/min) or those on dialysis.

Recent Clinical Evidence

Trixim, a brand name for the antibiotic Cefixime, and its combination formulations (such as those including clavulanic acid or ofloxacin), continues to be evaluated primarily within the context of antibiotic resistance and optimizing treatment strategies for bacterial infections.

Therapeutic Focus

Clinical evidence consistently supports Cefixime's use as a third-generation cephalosporin for a range of bacterial conditions. Recent data reinforces its effectiveness in treating acute infections of the respiratory tract (e.g., bronchitis), urinary tract (e.g., cystitis, pyelonephritis), and certain sexually transmitted diseases, such as gonorrhea. A key pharmacological advantage is its high stability in the presence of beta-lactamase enzymes, which are produced by some bacteria to resist other antibiotics. This stability makes it a valuable option where resistance to other commonly used antibiotics is a concern.

Primary Indication Pathogen Susceptibility
Upper/Lower Respiratory Tract Infections Streptococcus pneumoniae, Haemophilus influenzae
Urinary Tract Infections Escherichia coli, Proteus mirabilis
Uncomplicated Gonorrhea Neisseria gonorrhoeae

Safety and Administration

Recent clinical and surveillance data emphasize the importance of completing the full prescribed course to mitigate the risk of developing antibiotic resistance. As with other broad-spectrum antibiotics, common side effects include gastrointestinal issues like diarrhea and nausea. A significant safety consideration highlighted in clinical evidence is the potential for Clostridium difficile-associated diarrhea and, less commonly, severe skin reactions. Patients with pre-existing conditions, particularly kidney disease, require careful dosage adjustment, as Cefixime is primarily eliminated through the kidneys.

Frequently Asked Questions (FAQ)

Common questions about Trixim (FAQ)

Q: Is Trixim the same type of medicine as [similar drug name]?

A: Trixim is the brand name for the active ingredient Cefixime, which is classified as a third-generation cephalosporin antibiotic. According to official product information, this classification means it is chemically and functionally related to other prescription drugs within the cephalosporin family and is generally recognized for having a related mechanism of action against susceptible bacteria.

Q: Is there a generic version of Trixim available?

A: The active ingredient in Trixim is Cefixime, which is the generic name for the drug. Regulatory documents confirm that generic versions of Cefixime are available in various forms, including capsules, tablets, and oral suspension. This provides multiple available formulations of the medicine.

Q: Can Trixim affect mood or behavior?

A: Official regulatory documents list adverse reactions that affect the central nervous system, such as headache and dizziness. Although reported less frequently, changes like agitation, confusion, and irritability are also noted in the safety documentation. These effects are part of the reported safety information for the drug.

Q: Are there known interactions between Trixim and hormonal contraceptives?

A: Studies cited in regulatory-based drug reports indicate that antibiotics in this class may reduce the effectiveness of certain hormonal contraceptives, specifically those containing estradiol. Official information suggests this potential interaction may increase the risk of pregnancy or result in breakthrough bleeding.

Q: Does Trixim cause weight gain or loss?

A: Regulatory adverse reaction data lists both rapid weight gain and unusual weight loss among the reported side effects. However, the official documentation does not classify these events as common, meaning the frequency of these occurrences has not been established in the official data.

Q: Is it normal to feel tired when first taking Trixim?

A: Official regulatory documentation includes general tiredness and weakness among the reported adverse reactions for Trixim. While these effects are documented as a potential experience, they are not classified in the most frequent side effect category.

Q: Does Trixim contain any ingredients that cause allergic reactions?

A: Regulatory documents state that the chewable tablet formulation specifically contains phenylalanine, which is a substance to consider for individuals with Phenylketonuria (PKU). Official label information suggests individuals consult with a healthcare professional regarding all ingredients, including non-active ones, particularly if they have known allergies.

Q: Is Trixim a controlled substance?

A: No. Trixim (Cefixime) is classified as a prescription-only cephalosporin antibiotic. Official regulatory scheduling information confirms that it is not listed as a controlled substance in the US schedules.

Q: What happens if you suddenly stop taking Trixim?

A: Official regulatory information notes that stopping treatment prematurely may result in the infection not being fully treated and resolved. Furthermore, incomplete treatment can contribute to the bacteria developing resistance to antibiotics.

Q: Why is Trixim sometimes prescribed for conditions other than its main use?

A: While Trixim is primarily indicated for specific infections, regulatory information notes that it is also recognized for managing other bacterial conditions. These can include infections such as certain types of pneumonia, sinus infections, and specific forms of typhoid fever, when medically determined as appropriate.

Q: How long does Trixim stay in your system after stopping it?

A: Pharmacokinetic data from regulatory sources provides a measure called the serum elimination half-life. For Trixim, this typically ranges from 2.4 to 4 hours in adults with normal kidney function. This measure describes the time it takes for half of the drug to be eliminated from the bloodstream.

Q: Are the side effects of Trixim permanent?

A: Official adverse reaction data generally indicates that many common side effects, such as a transient elevation in liver enzymes or rash, are temporary (short-lived). For rare but serious reactions, like severe skin conditions, regulatory documents specify that they typically resolve once the medication is discontinued.

Q: Has Trixim been approved in many countries?

A: Yes, the active ingredient Cefixime (Trixim) is a widely approved medicine. Regulatory information is provided by major governmental health agencies across the globe, including the US FDA and the European EMA, confirming its status as an established treatment.

Q: What patient populations are generally excluded from using Trixim?

A: Trixim is contraindicated (should not be used) in patients with a history of severe allergy or hypersensitivity to Cefixime or other cephalosporin-class antibiotics. Additionally, official safety information indicates that safety has not been established for use in children younger than six months.

Q: Are there warnings about driving or operating machinery while on Trixim?

A: Regulatory documents list central nervous system adverse effects such as dizziness and headache among the possible reactions. These documented effects are part of the official safety information and may impact activities that require full concentration.

Q: Can Trixim be crushed or split?

A: Official guidance notes that the tablets are generally swallowed whole. Crushing or splitting is generally not recommended, which is often related to the specific formulation or a reported strong bitter taste.

Q: Is Trixim an antibiotic?

A: Yes, Trixim is classified as a third-generation cephalosporin antibiotic. This means it is a prescription-only medicine used specifically to kill or eliminate susceptible bacterial infections.

Q: Can Trixim be taken with antacids?

A: An interaction study cited in regulatory-based medical literature found that co-administration with an aluminum-magnesium type of antacid did not significantly change the amount of Cefixime absorbed into the bloodstream. This finding indicates that the antacid did not significantly alter the amount of Cefixime absorbed.

Q: Are there different strengths of Trixim available?

A: Yes, regulatory documents list Trixim as being available in various strengths and formulations. These include different strength tablets (e.g., 100 mg, 200 mg, 400 mg), capsules, and an oral suspension.

How should Trixim be stored and disposed of?

Storage and Disposal of Trixim (Cefixime)

The storage of Trixim must follow official regulatory specifications to maintain product stability and potency.

Storage Requirements

Formulation Required Storage Condition Stability Constraint
Capsules Store at Controlled Room Temperature (20 C to 25 C). Keep in original container.
Dry Powder Store below 30 C and protect from light and moisture. Prior to reconstitution.
Reconstituted Suspension May be kept at room temperature or refrigerated; container must be tightly closed. Discard unused portion after 14 days.

Disposal and Safety

All forms of this medicine must be stored out of the sight and reach of children. Unused or expired Trixim should be disposed of by utilizing community drug take-back programs or by following specific instructions for discarding it in household trash. This medicine is not recommended for flushing down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trixim found in:

A-Z Index: